Gene Solutions Taiwan has introduced triSure, a revolutionary non-invasive prenatal screening technology. This marks a definitive shift in the local clinical landscape, moving beyond basic chromosomal checks toward a new frontier of comprehensive genetic risk assessment.
While traditional Non-Invasive Prenatal Test (NIPT) has long been the gold standard for detecting common trisomies, Gene Solutions is challenging the status quo.
triSure is an all-in-one prenatal screening solution that integrates single-gene disorders, carrier screening, and chromosomal abnormalities into a single maternal blood draw. This addresses the growing demand among Taiwanese clinicians for more streamlined and comprehensive risk assessment for fetal and mother health.
As the trend of delayed childbearing continues across Asia, the demand for high-resolution genetic insights has never been higher. The arrival of triSure in Taiwan represents more than just a new test; it is progressing beyond conventional aneuploidy detection toward earlier, broader, and more clinically actionable genetic risk assessment.
